Global Pharmaceuticals & Biotech High Insider Buying

Aptamer Group

Market Cap: UK£22.3m

Provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.

FLUENT

Market Cap: US$28.7m

Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.

Lexaria Bioscience

Market Cap: US$27.8m

Operates as a biotechnology company.

Thiogenesis Therapeutics

Market Cap: CA$38.4m

A clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.

Cryosite

Market Cap: AU$41.0m

Provides outsourced clinical trials logistic services in Australia.

Emyria

Market Cap: AU$39.2m

Engages in delivering and developing of treatments for mental health and select neurological conditions in Australia.

Pharmaids Pharmaceuticals

Market Cap: ₹2.1b

Provides contract research and manufacturing services for pharma, biotech, agro, and chemical industries in India.

Biomark Diagnostics

Market Cap: €18.1m

Develops early-stage cancer diagnostic technology platform to detect and treat cancer.

Optimi Health

Market Cap: CA$27.5m

Operates as a GMP-certified pharmaceutical drug manufacturing company in Canada.

Voyageur Pharmaceuticals

Market Cap: CA$26.8m

Engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah.

Cellectar Biosciences

Market Cap: US$18.4m

A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.

Abpro Holdings

Market Cap: US$18.2m

A biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology.

Charlotte's Web Holdings

Market Cap: CA$23.9m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products.

BCAL Diagnostics

Market Cap: AU$25.6m

A screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer.

GeoVax Labs

Market Cap: US$16.5m

A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.

BioCardia

Market Cap: US$15.7m

A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.

Hemostemix

Market Cap: CA$19.3m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

PreveCeutical Medical

Market Cap: CA$17.1m

A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

Rize Oncology

Market Cap: US$12.1m

A biopharmaceutical company, focuses on the development of precision gene editing for human therapeutics applications.

Sharp Therapeutics

Market Cap: CA$15.0m

A preclinical-stage drug discovery company, develops therapeutics for genetic diseases.

Nanollose

Market Cap: AU$15.9m

A biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia.

Marvel Biosciences

Market Cap: CA$13.2m

A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.

OncoZenge

Market Cap: SEK 78.7m

A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.

BetterLife Pharma

Market Cap: US$7.9m

A biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.

Percheron Therapeutics

Market Cap: AU$10.9m

Engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia.

Chimeric Therapeutics

Market Cap: AU$9.8m

A clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia.

Calidi Biotherapeutics

Market Cap: US$6.2m

A clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States.

Patrys

Market Cap: AU$9.2m

Develops and commercializes antibody technologies for the treatment of cancer in Australia.

Rakovina Therapeutics

Market Cap: CA$8.0m

A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.

Blueberries Medical

Market Cap: CA$7.4m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

XORTX Therapeutics

Market Cap: CA$6.5m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

Roquefort Therapeutics

Market Cap: UK£3.5m

A material biotech company, engages in the development of medicines for the treatment of cancer.

Delivra Health Brands

Market Cap: CA$6.4m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

1933 Industries

Market Cap: CA$5.0m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

Indaptus Therapeutics

Market Cap: US$3.3m

A clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products.

Bespoke Extracts

Market Cap: US$3.3m

Together with its subsidiary, Bespoke Extracts Colorado, LLC, produces and sells pre-rolled marijuana cigarettes in the United States.